It has been shown that fibronectin (FN) splice variants EIIIA and EIIIB are overexpressed in the vasculature of many types of tumors, including breast, lung and prostate cancers and high-grade glioma, whereas absent in normal tissues (110–112). This evidence concerns the gene FN1 and prostate carcinoma.